Immunotherapy in thymic epithelial tumors: tissue predictive biomarkers for immune checkpoint inhibitors

Thymic epithelial tumors (TETs) are rare malignant neoplasms arising in the thymus gland. Nevertheless, TETs, including thymomas (TMs), thymic carcinomas (TCs), and thymic neuroendocrine neoplasms (TNENs), are the most common mediastinal malignancies overall. A multidisciplinary approach is required...

Full description

Bibliographic Details

Published in:	Exploration of Targeted Anti-tumor Therapy
Main Authors:	Stefano Lucà, Marina Accardo, Severo Campione, Renato Franco
Format:	Article
Language:	English
Published:	Open Exploration Publishing Inc. 2024-05-01
Subjects:	thymic epithelial tumors immunotherapy thymoma thymic carcinoma
Online Access:	https://www.explorationpub.com/Journals/etat/Article/1002229